GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we treat high blood sugar. These injectable drugs function to mimicking the body’s inherent GLP-1 https://socials360.com/story12403260/glp-1-a-revolutionary-breakthrough-in-glucose-care